X

Vous n'êtes pas connecté

Maroc Maroc - KNOWRIDGE.COM - A La Une - 21/Feb 11:23

Weight‑loss drug may cut alcohol use in half

For the first time, scientists have shown that tirzepatide—the main ingredient in the diabetes and weight‑loss drug Mounjaro—can reduce alcohol intake and relapse‑like drinking behavior in laboratory animals. The findings suggest that medications originally designed to control blood sugar and appetite might one day help treat alcohol use disorder, a condition that affects millions of […] The post Weight‑loss drug may cut alcohol use in half appeared first on Knowridge Science Report.

Articles similaires

Weight‑loss drug may cut alcohol use in half

knowridge.com - 21/Feb 11:23

For the first time, scientists have shown that tirzepatide—the main ingredient in the diabetes and weight‑loss drug Mounjaro—can reduce alcohol...

Popular weight loss drug may help protect vision in people with diabetes

knowridge.com - 13/Feb 10:47

A widely used diabetes and weight loss medication may do more than lower blood sugar and help people shed pounds. New research suggests that...

Hidden ingredient in weight‑loss pills may not be safe

knowridge.com - 24/Feb 01:09

New weight‑loss medicines are changing how doctors treat obesity, a condition that affects hundreds of millions of people around the world. These...

Hidden ingredient in weight‑loss pills may not be safe

knowridge.com - 24/Feb 01:09

New weight‑loss medicines are changing how doctors treat obesity, a condition that affects hundreds of millions of people around the world. These...

Sorry! Image not available at this time

Novo Nordisk shares fall after disappointing study. Novo’s CEO: “It will be the best in the market.”

cphpost.dk - 23/Feb 11:00

Novo Nordisk shares fell more than 16 percent after the company released results from a study of its weight loss drug candidate Cagrisema. The study...

Sorry! Image not available at this time

Novo Nordisk shares fall after disappointing study. Novo’s CEO: “It will be the best in the market.”

cphpost.dk - 23/Feb 11:00

Novo Nordisk shares fell more than 16 percent after the company released results from a study of its weight loss drug candidate Cagrisema. The study...

Zepbound Vs CagriSema: Which Weight Loss Drug Wins?

medindia.net - 25/Feb 15:24

New trial data show tirzepatide outperforms a GLP 1 combo in weight loss, reshaping obesity drug competition, and treatment strategies.

Zepbound Vs CagriSema: Which Weight Loss Drug Wins?

medindia.net - 25/Feb 15:24

New trial data show tirzepatide outperforms a GLP 1 combo in weight loss, reshaping obesity drug competition, and treatment strategies.

Fast-acting psychedelic shows promise for depression relief

knowridge.com - 22/Feb 11:49

Major depressive disorder is one of the most common and serious mental health conditions in the world. It affects how people think, feel, and function...

Fast-acting psychedelic shows promise for depression relief

knowridge.com - 22/Feb 11:49

Major depressive disorder is one of the most common and serious mental health conditions in the world. It affects how people think, feel, and function...